Recipharm is a contract development and manufacturing organization specializing in pharmaceutical products.
Business Model:
Revenue: $1.4B
Employees: 5,001-10,000
Address: Ioffice Vasagatan 10
City: Stockholm
State: stockholms län
Zip: 111 20
Country: SE
Recipharm is a contract development and manufacturing organization specializing in pharmaceutical products.
Contact Phone:
Contact Email:
Listed Exchange:
OMX
IPO Date:
4/4/2014
Ticker Symbol:
RECI-B
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2020 | Post-IPO Debt | $51.1M | 5/2018 | Post-IPO Debt | $58.9M | 4/2014 | IPO | $432.3M | 1/2016 | Post-IPO Equity | $32M | 9/2014 | Post-IPO Debt | $210M |
DNB Scandinavian Handelsbanken Swedbank |
9/2014 | Post-IPO Debt | 3 | $209.7M |
Swedbank DNB Svenska Handelsbanken Swedbank DNB Svenska Handelsbanken |
---|
Announced Date | Name | Price |
---|---|---|
2/2022 | GenIbet | |
11/2019 | Consort Medical | |
10/2018 | Sanofi - business | |
2/2017 | Kemwell’s pharmaceutical businesses | |
4/2016 | Cirrus Pharmaceuticals | |
4/2016 | Kemwell Biopharma | |
2/2016 | MITIM S.r.l | |
10/2015 | Nitin Lifesciences Ltd | |
6/2015 | OnTarget Chemistry | |
12/2014 | Flamel Technologies |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|